Solixir Pharma Private Limited
About Solixir Pharma Private Limited
Data last updated:
Solixir Pharma Private Limited is a private limited company based in Thasra, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2021PTC125945.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Raviraj Rajendrasinh Solanki and Meghrajsinh Nileshkumar Solanki.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 5038/6 Amar Complex Village – Dakor, Thasra, Gujarat, India – 388225.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.34 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹6.56 Lakh (net margin -18%) and EBITDA of -₹5.6 Lakh (EBITDA margin -15.4%). Revenue has grown at a compounded annual rate (CAGR) of 403% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. 5038/6 Amar Complex Village – Dakor, Thasra, Gujarat, India – 388225
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Solixir Pharma Private Limited
The main business activity of Solixir Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Solixir Pharma Private Limited FY 2025 filings available
Solixir Pharma Private Limited reported revenue of ₹36.34 Lakh (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Solixir Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 403% over three years, including 1% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Solixir Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.6 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.56 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Solixir Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -15.4% | •••• | •••• | •••• |
| Net Profit Margin | -18% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Solixir Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Solixir Pharma Private Limited
Solixir Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lotus Scan Centre Private Limited | ₹36.52 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Erode, Tamil Nadu, India |
| Simova India Lifesciences Private Limited | ₹36.48 Lakh (FY 2019) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Vital Clinic Private Limited. | ₹36.44 Lakh (FY 2024) | •••• | •••• | 149.0% | •••• | New Delhi, Delhi, India |
| Kliff Health Care Private Limited | ₹36.4 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Pranavayu Swadeshi Agro Healthcare Private Limited | ₹36.35 Lakh (FY 2025) | •••• | •••• | 380.0% | •••• | Mumbai, Maharashtra, India |
| Solixir Pharma Private Limited this company | ₹36.34 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Thasra, Gujarat, India |
| Niyama Care Private Limited | ₹36.34 Lakh (FY 2024) | •••• | •••• | -33.0% | •••• | Noida, Uttar Pradesh, India |
| Neetu Kidney Care Private Limited | ₹36.31 Lakh (FY 2024) | •••• | •••• | 126.0% | •••• | Varanasi, Uttar Pradesh, India |
| DN Optimum Health Care Services Private Limited | ₹36.29 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Puri, Odisha, India |
| Madhi Shiv Trading Private Limited | ₹36.28 Lakh (FY 2022) | •••• | •••• | •••• | Kanpur, Uttar Pradesh, India | |
| Prosperita Medi 360 Private Limited | ₹36.25 Lakh (FY 2022) | •••• | •••• | 11.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Solixir Pharma by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Solixir Pharma Private Limited
Solixir Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raviraj Rajendrasinh Solanki | Director | 29 Sep 2021 | 5 Years 0 Months | Current |
| Meghrajsinh Nileshkumar Solanki Also directs: Solixir Industries Private Limited | Director | 29 Sep 2021 | 5 Years 0 Months | Current |
| Roop Preet Kaur Gill | Director | 30 Oct 2021 | 4 Years 11 Months | Current |
Charges & Borrowings of Solixir Pharma Private Limited
Solixir Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Solixir Pharma Private Limited
Employment history and EPFO contributions of people linked to Solixir Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Solixir Pharma Private Limited
Solixir Pharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Roop Preet Kaur Gill was appointed as Director on 30 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Solixir Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Solixir Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Solixir Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Solixir Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Solixir Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Solixir Pharma Private Limited
Solixir Pharma is an active private limited company based in Thasra, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2021 (5+ years old) and is registered under CIN U24230GJ2021PTC125945.
Solixir Pharma reported revenue of ₹36.34 Lakh for FY 2025 (up 1% YoY).
Solixir Pharma has 3 current directors:
- Raviraj Rajendrasinh Solanki - Director
- Meghrajsinh Nileshkumar Solanki - Director
- Roop Preet Kaur Gill - Director
Solixir Pharma reported a net loss of ₹6.56 Lakh (net margin -18%) and EBITDA of -₹5.6 Lakh (EBITDA margin -15.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Solixir Pharma is 403% over three years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Solixir Pharma is U24230GJ2021PTC125945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solixir Pharma was incorporated on 29 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Solixir Pharma by revenue are Lotus Scan Centre Private Limited, Simova India Lifesciences Private Limited, Vital Clinic Private Limited, Kliff Health Care Private Limited, Pranavayu Swadeshi Agro Healthcare Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Roop Preet Kaur Gill was appointed as Director on 30 Oct 2021. Meghrajsinh Nileshkumar Solanki was appointed as Director on 29 Sep 2021. Raviraj Rajendrasinh Solanki was appointed as Director on 29 Sep 2021.
The registered office of Solixir Pharma is at Shop No. 50386 Amar Complex Village – Dakor, Thasra, Gujarat, India – 388225.
Solixir Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.